Topic Dossier
Pfizer's Lyme Disease Vaccine Shows Promising Results in Study
First article: 23 mar. 2026, 12:45
|
Last update: 23 mar. 2026, 12:45
|
1 source
|
1 article
Multiple sources. Less manipulation.
Editorial Analysis
Based on 1 source, 1 article
Pfizer's Lyme disease vaccine candidate has shown promising results in a recent study, offering hope for preventing the debilitating disease. The vaccine's effectiveness could significantly reduce the incidence of Lyme disease, which is transmitted through tick bites. Further trials and regulatory approvals are anticipated before the vaccine becomes widely available.Articles about this topic
Foto: Bloomberg
Pfizer Says Long-Awaited Lyme Vaccine Was Effective in Study
Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though fewer-than-expected cases in a study made it hard to determine how well it works on a large scale.
Read on Bloomberg →